Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

68
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
68
Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

78
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
78
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

95
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
95
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

81
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
81

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical Trial.

Circulation. Cardiovascular interventions·2025
Same author

Clinician perceptions of electronic health record and email nudge interventions to prevent unsafe opioid prescribing: A qualitative study.

Journal of opioid management·2025
Same author

Heart Failure and All-Cause Hospitalizations in Patients With Heart Failure: A Meta-Analysis.

JAMA network open·2024
Same author

Use of standard assessment of post-hemorrhagic ventricular dilation to improve collaboration with referring centers.

Journal of perinatology : official journal of the California Perinatal Association·2024
Same author

Deprescribing strategies in older patients with heart failure.

Internal and emergency medicine·2024
Same author

Resistant Hypertension: A Brief Review of Pathophysiology.

Journal of general internal medicine·2024

Related Experiment Video

Updated: Oct 29, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.5K

Adaptive Trials in Cardiology: Some Considerations and Examples.

John Mandrola1, Andrew D Althouse2, Andrew Foy3

  • 1Baptist Health Louisville, Louisville, Kentucky, USA.

The Canadian Journal of Cardiology
|July 12, 2021
PubMed
Summary

Adaptive trials offer a promising approach to strengthen medical evidence. This review covers adaptive trial principles, types, examples, and discusses their benefits and drawbacks to encourage wider adoption.

More Related Videos

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.6K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.7K

Related Experiment Videos

Last Updated: Oct 29, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.5K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.6K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.7K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Medical Research Design

Background:

  • Adaptive trials are increasingly recognized for their potential to improve medical intervention evidence.
  • Despite regulatory support, community acceptance of adaptive trial designs remains a challenge.

Purpose of the Study:

  • To elucidate the fundamental principles of adaptive trial design.
  • To categorize and illustrate diverse types of adaptive trials with practical examples.
  • To critically evaluate the advantages and challenges associated with various adaptive trial methodologies.

Main Methods:

  • This review synthesizes existing literature on adaptive trial designs.
  • It systematically describes core concepts and classifications of adaptive trials.
  • Illustrative examples are presented to demonstrate real-world applications.

Main Results:

  • Adaptive trials offer flexibility in trial conduct and data analysis.
  • Different adaptive designs present unique benefits, such as efficiency and ethical considerations.
  • Key challenges include complexity in design, statistical analysis, and regulatory navigation.

Conclusions:

  • Adaptive trial designs represent a significant advancement in clinical research methodology.
  • Addressing community resistance through clear communication of benefits and challenges is crucial for broader implementation.
  • This review aims to foster greater understanding and acceptance of adaptive trial designs in medical research.